Skip to main content
TipRanks
Go Ultimate75% OFF

Noevir Holdings Co., Ltd. (4928) AI Stock Analysis

0 Followers
JP:4928

Noevir Holdings Co., Ltd.

(TSE/TYO:4928)

Select Model
Rating:72Outperform
Price Target:JPY 4,962.00â–²(7.99% Upside)
Action:reiterated
Date:11/11/26

The score is driven primarily by strong financial quality—especially very low leverage and solid profitability—tempered by weaker cash flow conversion in 2026 and a mature/softening revenue trend. Technical indicators are a notable near-term headwind (negative MACD and trading below key short-term averages), while valuation is supported by a high dividend yield with a moderate P/E.

Positive Factors
High profitabilitySustained high gross margins and low-teens net margins indicate strong product economics and pricing quality in the cosmetics and personal-care portfolio. This profitability provides capacity to fund operations, support shareholder returns, and absorb moderate cost or demand pressure.
Negative Factors
Mature and declining revenueA flat-to-declining revenue trend suggests limited current expansion in Noevir’s established cosmetics and personal-care markets. Without renewed top-line growth, future earnings improvement will depend more heavily on efficiency, mix, or pricing rather than broader demand.

Noevir Holdings Co., Ltd. (4928) vs. iShares MSCI Japan ETF (EWJ)

-10%-5%0%5%10%15%20%25%30%JP:4928+6.09%EWJ+16.06%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
JPY 156.95B
Dividend Yield
5.05%
Average Volume (3M)
83.94K
Price to Earnings (P/E)
19.1
Beta (1Y)
0.30
Revenue Growth
-3.20%
EPS Growth
2.32%
Country
Japan
Employees
1,354
Sector
General
Sector Strength
55
Industry
Household & Personal Products

Noevir Holdings Co., Ltd. Business Overview & Revenue Model

Company Description

Noevir Holdings Co., Ltd. is a diversified Japanese conglomerate involved in the creation, production, and distribution of cosmetics, pharmaceuticals, and health food items. Its operations span a wide international footprint, including key markets su...

How the Company Makes Money

Noevir Holdings makes money mainly through consolidated sales generated by its operating subsidiaries’ cosmetics and personal care businesses. Revenue is primarily earned from (1) selling skincare and cosmetics products to end customers via establish...

Noevir Holdings Co., Ltd. Financial Statement Overview

Summary

Strong overall fundamentals supported by high, stable profitability (gross margin mid-to-high 60s; net margin low-teens) and an exceptionally conservative balance sheet with very low leverage (debt-to-equity ~1%–2%). Offsetting factors are flat-to-declining revenue in 2026 and weaker cash conversion/volatility in 2026 where operating cash flow covered only about half of net income and free cash flow declined versus the prior year.

Income Statement

78Positive

Balance Sheet

92Very Positive

Cash Flow

64Positive
Financial statement breakdown
BreakdownTTMSep 2026Sep 2025Sep 2024Sep 2023Sep 2022
Income Statement
Total Revenue62.65B62.65B64.72B63.82B62.55B61.14B
Gross Profit42.28B42.28B43.28B43.16B42.56B42.09B
EBITDA19.39B10.48B11.94B12.44B12.24B11.57B
Net Income8.22B8.22B8.03B7.97B7.67B7.59B
Balance Sheet
Total Assets75.45B75.45B76.49B76.47B77.25B76.78B
Cash, Cash Equivalents and Short-Term Investments25.67B25.67B26.93B29.22B28.88B29.75B
Total Debt664.00M664.00M742.00M828.00M914.00M1.00B
Total Liabilities20.82B20.82B22.28B22.56B24.04B24.39B
Stockholders Equity54.16B54.16B53.77B53.48B52.79B52.06B
Cash Flow
Free Cash Flow03.93B5.66B8.50B6.89B5.30B
Operating Cash Flow04.68B7.93B9.12B7.62B5.84B
Investing Cash Flow02.07B-2.42B1.52B-3.54B-255.00M
Financing Cash Flow0-8.18B-7.92B-7.71B-7.49B-7.38B

Noevir Holdings Co., Ltd. Technical Analysis

Technical Analysis SentimentPositive
Last Price4595.00

Price Trends

50DMA4572.47Positive
100DMA4496.96Positive
200DMA4387.47Positive

Market Momentum

MACD-8.81Positive
RSI51.60Neutral
STOCH42.86Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4928, the sentiment is Positive. The current price of 4595.00 is below the 20-day moving average (MA) of 4600.50, above the 50-day MA of 4572.47, and above the 200-day MA of 4387.47, indicating a neutral trend. The MACD of -8.81 indicates Positive momentum. The RSI at 51.60 is Neutral, neither overbought nor oversold. The STOCH value of 42.86 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4928.

Noevir Holdings Co., Ltd. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:4928 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:4452JP:445273OutperformJPY 3.59T25.9412.88%1.93%6.31%18.40%
JP:4928JP:492872OutperformJPY 156.61B19.10―5.05%-3.20%2.32%
JP:4927JP:492771OutperformJPY 323.21B29.186.84%3.58%1.17%10.12%
JP:4911JP:491168NeutralJPY 1.63T35.23―1.19%5.79%―
JP:4922JP:492267NeutralJPY 335.23B26.814.51%2.34%4.49%70.29%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%

* General Sector Average

Performance Comparison

0%20%40%60%JP:4928JP:4452JP:4922JP:4927JP:4911Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
JP:4928 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:4928Noevir Holdings Co., Ltd.4595.00292.266.79%
JP:4452Kao Corp4006.00833.7226.28%
JP:4922Kose Corporation5989.001042.9021.09%
JP:4927Pola Orbis Holdings 1451.00185.1414.63%
JP:4911Shiseido Company,Limited4205.001830.1077.06%

Noevir Holdings Co., Ltd. Corporate Events

Noevir Approves 232-Yen Year-End Dividend

Nov 10, 2026

Noevir Holdings’ board approved a year-end dividend from retained earnings for the fiscal year ended September 30, 2026, with a record date of September 30, 2026, and an effective date of December 10, 2026. The dividend is 232 yen per share, compared...

Noevir Holdings Announces Proposed Changes to Representative Directors and Board Members

Nov 10, 2026

Noevir Holdings announced proposed changes to its representative directors, directors, Audit & Supervisory Board members, executive officers and general managers at the company and two subsidiaries. The changes include Hiroshi Okura becoming chairman...

Noevir Holdings Reports Fiscal 2026 Results as Sales and Operating Income Decline

Nov 10, 2026

Noevir Holdings Co., Ltd. reported consolidated results for the fiscal year ended September 30, 2026, with net sales of 62.651 billion yen, down 3.2% year on year, and operating income of 9.424 billion yen, down 14.9%; ordinary income fell 16.0% to 9...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 11, 2026